Melatonin Vitabalans

Melatonin, the active ingredient in Melatonin Vitabalans, is a melatonin receptor agonist presented as an oral tablet for oral use. It is used to help regulate sleep cycles in adults experiencing insomnia, jet lag or other sleep disturbances.

GNH USA supplies Melatonin Vitabalans as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Melatonin Vitabalans acts on melatonin receptors to support normal circadian rhythm and is indicated for the following sleep‑related conditions. - Insomnia: helps reduce time to fall asleep and improve sleep continuity. - Sleep disorders: assists in establishing a regular sleep pattern for individuals with chronic sleep difficulty. - Jet lag: aids adjustment of the internal clock after rapid travel across time zones.

Melatonin Vitabalans may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness or daytime sleepiness. - Headache. - Dizziness. - Nausea or mild stomach upset. - Vivid dreams.

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling). - Severe skin eruption or Stevens‑Johnson syndrome. - Mood changes such as depression or agitation. - Hallucinations or psychotic symptoms (rare).

When using Melatonin Vitabalans, consider the following precautions to ensure safe and effective use. - Medical supervision: use under guidance of a healthcare professional. - Age restrictions: not recommended for children unless specifically advised. - Operating machinery: avoid driving or operating heavy equipment if drowsy. - Concurrent sedatives: monitor for increased sedation when combined with other CNS depressants. - Pregnancy and lactation: safety not established; discuss with physician. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Melatonin can interact with other medicines; be aware of the following potential interactions.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, antihistamines): may increase sedation. - Anticoagulants (e.g., warfarin): may enhance bleeding tendency.

Moderate Interactions (Monitor Closely): - CYP1A2 inhibitors (e.g., fluvoxamine): may raise melatonin plasma levels. - CYP1A2 inducers (e.g., rifampin): may reduce melatonin effectiveness. - Immunosuppressants (e.g., cyclosporine): may alter drug concentrations.